Depressive Disorder, Major: all 2,805 studies
Page 13 of 29. Open to participants first (565), then studies with results posted, then the rest; newest registration first within each.
- Gottman Couple Therapy Program in Treatment of Depressed Female PartnersCompletedNCT07748845Not applicable
- Effect of Participating in a Study of Causes of Pregnancy Loss on Mental Health Outcomes: A Target Trial Emulation Using the COPL Cohort and Danish National RegistriesActive, not recruitingNCT07684677Not applicable
- Transcranial Magnetic Stimulation in Depression.CompletedNCT07638202Not applicable
- Electrophysiological Biomarkers in Accelerated TMS for DepressionCompletedNCT07615387Not applicable
- The Effectiveness of a One-stop Electronic Clinic for Psychological Service (eClinic) in Hong KongCompletedNCT07597967
- A Study of SEP-380135 in Adults With Schizophrenia or Major Depressive EpisodeCompletedNCT07549581Phase 1
- Electroconvulsive Therapy Versus Intravenous Ketamine in Treatment-Resistant Major Depressive DisorderCompletedNCT07526454Not applicable
- Magnesium Supplementation With Fluoxetine for Cognitive Function in DepressionCompletedNCT07521358Not applicable
- Treatment Response In ECT PatientsActive, not recruitingNCT07463911
- Transcranial Direct Current Stimulation (tDCS) in Different Psychiatric DisordersCompletedNCT07452835Not applicable
- A Study to Assess the Skin Irritation and Sensitization of Selegiline TDS in Healthy SubjectsActive, not recruitingNCT07452692Phase 1
- A Clinical Trial of Add-on Oral Slow-release Ketamine Treatment in Major DepressionActive, not recruitingNCT07396272Phase 2
- Prediction of REsponse to Depression Interventions (Accelerated rTMS) Using Clinical and TD-fNIRS MeasurementsTerminatedNCT07294924
- Predictors of rTMS and Group Therapy Efficacy in Adolescent DepressionCompletedNCT07283419
- Comparison of Propofol and Ketofol as Induction Agents for Electroconvulsive TherapyCompletedNCT07273851Not applicable
- A Study to Evaluate Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) in Participants With Major Depressive Disorder (MDD)CompletedNCT07258485
- ENX-104 MAD Study for Participants With Major Depressive Disorder With Anhedonia (aMDD)CompletedNCT07253324Phase 1
- Efficacy and Safety Study of Levomilnacipran Hydrochloride Extended-Release Capsules in Major Depressive DisorderCompletedNCT07253207Phase 3
- Accelerated High-Dose tDCS for DepressionActive, not recruitingNCT07226011Not applicable
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Characteristics of (R)-Ketamine Hydrochloride Nasal Spray in Patients With Depression and Acute Suicidal Ideation or BehaviorCompletedNCT07193901Phase 2
- Efficacy and Safety of Task-specific, Biomarker-driven, HD-ctACS inTRD.Active, not recruitingNCT07184697Not applicable
- High-Frequency vs. Theta-Burst TMS for DepressionCompletedNCT07181226Not applicable
- Retrospective Observational Study of Intensity Effects in Psychedelic-assisted TreatmentActive, not recruitingNCT07164287
- Accelerated TMS for MDDActive, not recruitingNCT07147218Not applicable
- A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Adult Participents With Major Depressive DisorderCompletedNCT07101120Phase 2
- Chart Review of Patients Undergoing Ketamine Treatments for DepressionCompletedNCT07099235
- A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)Active, not recruitingNCT07076407Phase 3
- Effect of Aerobic Exercise on Biomarkers in DepressionCompletedNCT07062783Not applicable
- 6 Weeks Right-Amygdala TIS for DepressionCompletedNCT07059143Not applicable
- Effectiveness of Traditional Chinese Metacognitive Training (MCT) in Patients With Schizophrenia, Depression, or Bipolar Disorder Attending a Psychiatric Day Hospital in TaiwanCompletedNCT07051746Not applicable
- EEG-Triggered rTMS and Group Therapy for Adolescents With Depression and Self-HarmCompletedNCT07047534Not applicable
- An Interactive Mobile Health (mHealth) App as Intervention for High Anxiety and Depression in College StudentsCompletedNCT07017569Not applicable
- Mood Effects of Serotonin Agonists: DepressionCompletedNCT07017478Early Phase 1
- Integral Cognitive Remediation for DepressionCompletedNCT07014683Not applicable
- Caregiver Depression in a Low-Resource Setting: Socio-Demographic Predictors of Major Depressive Disorder Among Family Caregivers of Breast Cancer Patients in PakistanCompletedNCT06992167
- Physical Activity-based Intervention in Depressed Patients: Clinical, Neurophysiological, Epigenetic and Metabolic CorrelatesActive, not recruitingNCT06989944Not applicable
- GW117 ODT （Orally Disintegrating Tablets） Safety and Pharmacokinetics Study in Healthy SubjectsCompletedNCT06964711Phase 1
- Feasibility Pilot of Accelerated Stimulation With TMS for Treatment of Major Depressive Disorder (FAST-MDD)CompletedNCT06961851Early Phase 1
- Is Betwixt App Effective and Acceptable?CompletedNCT06958887Not applicable
- Efficacy of Dextromethorphan-Bupropion Versus SSRIs in the Treatment of Major Depressive DisorderCompletedNCT06957223Not applicable
- Deciphering Principles of Network Dynamics Underlying Depression Symptom Severity From Multi-day Intracranial Recordings in Patients With Major DepressionCompletedNCT06953362
- A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge)Active, not recruitingNCT06941844Phase 3
- Neurobiological Mechanisms of Pathological Rumination and Effects of AripiprazoleActive, not recruitingNCT06937476Not applicable
- Near-infrared Transcranial Laser Therapy in Subjects With Major Depressive DisorderCompletedNCT06934135Not applicable
- IWLS for Major Depressive Disorder: An Open-Label Study of Safety, Tolerability, and EfficacyActive, not recruitingNCT06922812Not applicable
- An Open-Label Study of Azetukalner in Major Depressive DisorderActive, not recruitingNCT06922110Phase 3
- Individualized Non-invasive Brain Stimulation for the Treatment of Major Depressive DisorderCompletedNCT06874374Not applicable
- Lemborexant for the Treatment of Residual Insomnia in Major Depressive Disorder (MDD)TerminatedNCT06843187Phase 2
- A Phase II Study to Evaluate NH102 for DepressionCompletedNCT06842992Phase 2
- Study to Evaluate Efficacy and Safety of Ropanicant in MDD PatientsCompletedNCT06836063Phase 2
- Sustained Ketamine Effectiveness for Suicidal IdeationCompletedNCT06806475
- Racial Disparities in Antidepressant Treatment After a Psychiatric ConsultationActive, not recruitingNCT06799078
- A Study to Evaluate Efficacy and Safety of GW117 Tablets in Major Depressive DisorderCompletedNCT06796868Phase 2
- A Study of ONO-1110 in Patients With Major Depressive DisorderCompletedNCT06792136Phase 2
- Effect of Probiotic Supplement on Improvement of Depressive Symptoms in Patients With Substance-Induced Depressive DisorderCompletedNCT06790823Phase 1/2
- Detection Algorithm for Recurrence or Relapse of Depression Thanks to a SmartwachActive, not recruitingNCT06789822Not applicable
- A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive DisorderCompletedNCT06785012Phase 2
- Perioperative Depression, an Observational Cohort StudyActive, not recruitingNCT06783842
- A Randomized Study of Azetukalner Versus Placebo in Major Depressive DisorderActive, not recruitingNCT06775379Phase 3
- Cognitive Flexibility in Depression and TMS ResponseCompletedNCT06775054Not applicable
- NQ TMS for MDD Therapy Using 1 Day x 3 Sessions Protocol for Adult PatientCompletedNCT06772987Not applicable
- Acupoint Thermal Radiation Characteristics in Adolescents with MDDCompletedNCT06750640
- The Brain-Heart-Gut ConnectionCompletedNCT06748274Not applicable
- Effect of Psilocybin Only and Psilocybin Assisted Cognitive Behavioral Therapy in the Management of Major Depressive Disorder and Associated Metabolic, Immune, Inflammatory, Neuroplasticity and Electrical Activity MarkersCompletedNCT06746441Phase 2
- Generated AI-informed Intervention (Emohaa) vs Group ACT vs WL on Emotional DistressCompletedNCT06735807Not applicable
- A Study to Evaluate the Efficacy and Safety of REL-1017 As Adjunctive Treatment of Major Depressive Disorder (MDD)WithdrawnNCT06735079Phase 3
- Long-term Potentiation Disruption Underlying Cognitive Impairment in ECTWithdrawnNCT06733558Early Phase 1
- Dose-Optimized and Spaced Transcranial Direct Current Stimulation for Treatment-Resistant DepressionCompletedNCT06730841Not applicable
- Stingless Bee Honey Augmentation in Major Depressive DisordersCompletedNCT06723249Not applicable
- Group Acceptance and Commitment Therapy (ACT) Among Depressive Patients in Kelantan, MalaysiaCompletedNCT06710912Not applicable
- The Effect of Transcranial Magnetic Stimulation Treatment on Microvasculature Stracture of the Retina and the ChoroidCompletedNCT06708013Not applicable
- Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIVSuspendedNCT06705478Phase 2
- Online Writing Intervention for Major Depressive DisorderCompletedNCT06699719Not applicable
- Relief From Stress Via Social Protection in SenegalActive, not recruitingNCT06698471Not applicable
- Theta Burst Stimulation for Refractory Depression in Autism Spectrum DisorderCompletedNCT06670040Not applicable
- Impact of Anxiety and Depression on Implicit and Explicit Memory PerformanceCompletedNCT06663423
- Cognitive Effects Associated With Hippocampal Neurogenesis Induced by ECT in the Treatment of DepressionCompletedNCT06661616
- A Multiple Case Study of Schema Therapy for Difficult-to-treat Depression- DEPRE-ST*CaseCompletedNCT06655623Not applicable
- Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic PsychedelicsTerminatedNCT06624137
- Efficacy of Psychological Intervention for Children With CancerStatus unknownNCT06620445Not applicable
- A Study to Assess Adverse Events of Fosigotifator (ABBV-CLS-7262) in Adults With Major Depressive DisorderTerminatedNCT06618118Phase 1
- Stress Management With Real-time Bio-signal BiofeedbackCompletedNCT06616116Not applicable
- The Effects of Transcranial Magnetic Stimulation on Retina and Choroidal StructuresCompletedNCT06615804Not applicable
- Common Factors Group Psychotherapy for General Mental Health ConcernsWithdrawnNCT06614842Not applicable
- Effects of Ghrelin Administration on MotivationCompletedNCT06576440Not applicable
- A Study to Explore the Effect of SP-624 on Brain Network Analytics in Healthy Adults and Adults With Major DepressionCompletedNCT06570369Phase 1
- "A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"Active, not recruitingNCT06564818Phase 3
- Optimize and Predict Antidepressant Efficacy for Patient With MDD Using Multi-omics Analysis and AI-predictive ToolActive, not recruitingNCT06550037
- Transcranial Direct Current Stimulation (tDCS) in Young Individuals with Major Depressive Disorder: a Literature Review and Feasibility StudyCompletedNCT06518642Not applicable
- A Study of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy and Long-term Extension Treatment With AticaprantTerminatedNCT06514742Phase 3
- i-CBT and IV Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical TrialActive, not recruitingNCT06480500Phase 2
- Amygdala TIS for DepressionCompletedNCT06477276Not applicable
- A Study to Assess Serotonin Transporter Occupancy of Healthy Adults Using 11C-DASB PETCompletedNCT06476509Phase 1
- SAINT for MDD in an Inpatient Setting Follow-onTerminatedNCT06462820Phase 2/3
- Evaluation of Response to a Course of Repetitive Transcranial Magnetic Stimulation Using Vocal BiomarkersSuspendedNCT06451835
- Prediction of the Response to a Course of Transcranial Magnetic Stimulation (rTMS) Based on Heart Rate VariabilitySuspendedNCT06451809
- Inflammatory Markers as Predictors of the Efficacy of Electroconvulsive Therapy (ECT) in Major Depression PatientsCompletedNCT06439797
- Behavioural Activation Therapy and Esketamine for Resistant DepressionTerminatedNCT06431386Not applicable
- Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD)CompletedNCT06423781Phase 2
- Efficacy and Safety Study of BHV-7000 Monotherapy in Major DepressionCompletedNCT06419608Phase 2